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CONCISECOMMUNICATION

parvum
Pathogenesis of Human and Bovine Cryptosporidium
in Gnotobiotic Pigs
Sonia J. Pereira,1'2Norma E. Ramirez,1'2 Lihua Xiao,3
and Lucy A. Ward1'2

lFood Animal Health Research Program, Ohio Agricultural Research
and Development Center, and 2Departmentof VeterinaryPreventive
Medicine, College of VeterinaryMedicine, Ohio State University,
Wooster; 3ImmunologyBranch, Division of Parasitic Diseases, Centers
for Disease Control and Prevention, Atlanta, Georgia

To compare the pathogenesis of human genotype 1 (HuGl) and bovine genotype 2 (BoG2)
Cryptosporidiumparvum, neonatal gnotobiotic pigs were given 1-10 HuGl or BoG2 oocysts.
The prepatent and patent periods were significantly longer for HuGl than for BoG2 C parvum
(prepatent, 8.6 vs. 5.6 days; patent, 16.6 vs. 10.3 days). BoG2-infected pigs developed significantly more severe disease than did HuGl-infected pigs. BoG2 parasites were seen microscopically throughout the intestines during the prepatent and patent periods. HuGl parasites
were only detected during the patent period in the ileum and colon but colonized the mucosal
surface in significantly larger numbers than did BoG2. Moderate-to-severe villus/mucosal
attenuation with lymphoid hyperplasia was seen throughout the intestines of BoG2-infected
pigs, whereas lesions in HuGl-infected pigs were mild to moderate and restricted to the ileum
and colon. These findings provide additional support for the hypothesis that human and
bovine C. parvum genotypes may be separate species.

Cryptosporidiumparvum causes acute infectious diarrhea in
humans and animals worldwide. Molecular studies have identified at least 2 major genotypes within human-pathogenic C.
parvum: human genotype 1 (HuGl) and bovine genotype 2
(BoG2). These genotypes have biological differences in terms
of host range; BoG2 isolates appear to be infectious for a wide
variety of mammalian species, whereas HuGl isolates appear
to be highly selective, infecting principally humans [1]. This
difference is important, because most human cases of cryptosporidiosis ^750Zo)are caused by HuGl; ^507o are caused by
BoG2 [1, 2].
The biological behavior of BoG2 C. parvum has been studied
in several animal models, including the gnotobiotic pig [3-7],
and can be defined by time to onset of oocyst shedding, or
prepatent period; duration of shedding, or patent period; and
severity of disease and pathologic lesions. The prepatent periods
of BoG2 isolates in calves [5], mice [6], pigs [3], and humans
[7] vary considerably. BoG2-infected calves and gnotobiotic
pigs typically show symptoms of moderate-to-severe diarrhea

with weight loss and sometimes death due to dehydration and
wasting. The biological behavior of HuGl C parvumin animals
has not been studied until now because of the parasite's inability
to infect nonhuman hosts. However, longitudinal studies in
humans suggest that the human and bovine genotypes behave
differently in the human host [8, 9].
High doses (thousands to millions of oocysts) of BoG2 C.
parvum are traditionally used in animal pathogenesis studies,
although most naturally acquired Cryptosporidiuminfections
result from ingestion of relatively few oocysts. In fact, the risk
of C parvum infection is heightened as a result of the parasite's
low infective dose. The recent finding that HuGl isolates can
infect neonatal gnotobiotic pigs [3, 4] has made possible comparative studies on the biological behavior of HuGl and BoG2
C parvum in a single host species. We believe that the present
study is the first to compare the clinical and pathologic outcome
of HuGl and BoG2 C parvum infections by using small numbers of oocysts (1-10 oocysts) to better emulate naturally acquired infections.
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BoG2 C. parvumGCH1 was supplied to our laboratory by S.
Tzipori (TuftsUniversity,School of VeterinaryMedicine,Grafton,
MA). GCH1 was first isolated from a patient with AIDS and was
subsequentlymaintainedby passage in neonatal calves. HuGl C
parvumH2132 and H2265 were obtained from persons infectedin
waterborne disease outbreaks in South Carolina and Nebraska,
respectively.Each C. parvumisolate was serially passaged in gnotobiotic oies and confirmedto be BoG2 or HuGl before and after
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selected pig passages by nested polymerasechain reaction restriction fragment-length polymorphism (RFLP) targeting the small
subunit rRNA gene [10].
For the first pig passage, day-old gnotobiotic pigs were fed 103
and 105 oocysts extracted from infected calf or human feces by
immunomagneticbeads (1MB) (Dynabeads Anti-Cryptosporidium
[no. 730.01]; Dynal). Pigs were euthanized 24-48 h after the detection of oocyst shedding by acid-fast stain and UV light microscopy[11],and theirintestinalcontentswerecollectedand stored
at 40C. For subsequentpassages, oocysts were extractedfrom pig
intestinalcontents by 1MB and counted by hemocytometer.Sterile
water was added to create a suspension of 103oocysts/mL, and a
5-juLdroplet of each oocyst suspensionwas then placed on a drop
slide and examinedmicroscopically(X400 magnification).Droplets
with 1-10 oocysts were covered with 50 juLof Wo low-meltingpoint agarose (Life Technologies) and fed to pigs within 1 h. In
the present study, 1-10 oocysts from the intestinalcontents of the
third (for strain H2132) and fifth (for strains GCH1 and H2265)
pig passages were isolated as describedand fed to pigs.
Forty gnotobiotic pigs were derivedand maintainedas described
elsewhere[12]. At age 1 day, 15 pigs were fed 1-10 HuGl oocysts,
15 pigs were fed 1-10 BoG2 oocysts, and 10 pigs were fed agarose.
Pigs were monitored daily for clinical disease and oocyst shedding
by acid-fast stain and UV light microscopy [11]. Feces were examinedand scoredas follows: 0, normal; 1, pasty;2, opaqueliquid;
and 3, watery.Diarrheawas consideredto be presentat scores ^2.
Dehydration was described as mild (visible vertebrae),moderate
(prominentvertebraeand eyes retractedin orbit^ mm), and severe
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(prominent protruding vertebral and pelvic bones and eyes retracted in orbit ^ mm).
Three pigs from each infected group and 2 uninfected control
pigs were killed 3 days after inoculation (DAI) and 0, 7, 21, and
42 days after onset (DAO) of oocyst shedding.Intestinalcontents
from each pig were collected and stored at 40C. Sections of duodenum,jejunum,ileum, and colon were collectedas describedelsewhere [13], placed in fixative (Prefer;Anatech) for 24-48 h, processed through graded alcohols, embedded in paraffin, sectioned
at 4 jitm,and stained with hematoxylin-eosin(HE).
Slides were coded and examined by an examiner who had no
knowledge of infecting genotype or strain. The average intestinal
infection rate per 100 linear micrometersin 10 random fields per
intestinal section was evaluated at X400 magnificationand scored
as follows: 0, no parasites detected; 1, 1-10 parasites/100jum;2,
11-30 parasites/100fim; and 3, ^0 parasites/100fim. Villus height
and width, crypt height and width, and epithelialcytoplasmicvacuolation at villus tips were used to determinethe extent of mucosal
attenuationand were scored as follows: 0, same as in control pigs;
1, mild; 2, moderate;and 3, severe. The extent to which lymphoid
cells had infiltratedthe submucosaand the laminapropriaand the
size of organizedsubmucosallymphoidfollicles(i.e., Peyerpatches)
determinedthe extent of lymphoid hyperplasiaand was scored as
follows: 0, same as in control pigs; 1, mild; 2, moderate; and 3,
marked.
Between-groupdifferencesin mean diarrheascores,dehydration,
and prepatent and patent periods were identified by the general
linear model (SAS Institute).We used x2 analysis to comparedata

showpeakoocystinfectionratesin ileum (A and B) villusattenuationin smallintestine(C andD), andlymphoid
Figure 1. Photomicrographs
hyperplasiain cecum(E and F) tissuesfromgnotobioticpigs infectedwith bovine (A, C, andE) or human(B, D, andF) Cryptosporidium
parvum
stain;originalmagnifications,X400 [A and B] and X25 [C-Fl).
(hematoxylin-eosin

C parvumin GnotobioticPigs
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Table 1. Mean scoresfor pathologiclesionsin the duodenum(D), jejunum(J), ileum(I), and colon (C)
of gnotobioticpigs infectedwith humanand bovine Cryptosporidium
parvum.
Parasite burdena
Genotype, time point
Human
3 Days after inoculation
Days after onset
0
7
21
42
Bovine
3 Days after infection
Days after onset
0
7
21
42

DJ

Villus attenuation0

Lymphoid hyperplasia15

IC

DJ

IC

DJ

IC

0

0

0

0

0

0

0

0

0

0

0

0

0
0
0
0

0
0
0
0

2.3
2
0
1

1.7
1.7
1
0

0
0
0
0

0
0
0
0

1
1
1.5
1.6

1
1
1
1

0
0
0.7
0

0
0
1
0

1
1
1
1

1
1
0.1
0

1

0

0

0

1

0

0.7

0

0.1

0

0

0

1
1.3
0
0

0.3
0.7
0
0

0.3
1.3
1
0

1
1
0.3
0

1.7
1
1
1

1
1.5
1
1

1
1.5
1
1.3

1
1.5
2
1.3

1.1
1.1
1
0

1
1
0.5
0

0
1
1
0

1
0.5
2
0

NOTE. For each C. parvum genotype, 3 pigs were infected.
d
b Score: 0, no parasites detected; 1, 1-10 parasites/100 /xm; 2, 11-30 parasites/100 /mi; 3, ^0 parasites/100 /mi.
b
Score: 0, same as control pigs; 1, mild; 2, moderate; 3, marked.
c Score: same as control
0,
pigs; 1, mild; 2, moderate; 3, severe.

for pathologic lesions between groups. P ^ .05 was consideredto
be significant.

Results
The prepatent period for HuGl-infected pigs was significantly longer (mean ? SE, 8.6 ? 0.5 days) than for BoG2-infected pigs (5.6 ? 0.6 days) {P = .001). HuGl-infected pigs
shed oocysts for 16.6 ? 1.8 days, whereas BoG2-infected pigs
shed oocysts for 10.3 ? 1.7 days {P = .03). In the first week
after the onset of shedding, HuGl-infected pigs had daily fecal
scores of 1.8 ? 0.16, and BoG2-infected pigs had significantly
higher daily fecal scores of 2.6 ? 0.14 (P = .009). Daily fecal
scores of control pigs were 0.48 ?0.8. During the patent period,
BoG2-infected pigs developed moderate-to-severe dehydration
and weight loss, whereas HuGl-infected pigs showed mild-tono dehydration or weight loss in comparison with control pigs.
Microscopic examination of HE-stained tissue sections revealed BoG2 parasites in the duodenum, jejunum, ileum, and
colon (figure \A). BoG2 parasites were detected in the intestinal
tissues of pigs killed during the prepatent (3 DAI) and patent
(0-21 DAO) periods. However, HuGl parasites were only seen
during the patent period in the ileum and colon. No HuGl
parasites were detected in the duodenum and jejunum at any
time during the study (table 1). Significantly more HuGl parasites than BoG2 parasites were observed per villus in the ileum
(P = .05) at 0 DAO (figure \A and \B).
Moderate lymphoid hyperplasia was seen at 0 DAO in the
duodenum, at 7 DAO in the jejunum and ileum, and at 7 and
21 DAO in the colon of BoG2-infected pigs (table 1 and figure
\E). Other intestinal sections showed mild lymphoid hyperplasia and infiltration of scattered neutrophils. Lymphoid hyperplasia in the HuGl-infected pigs was noted only during the
patent period. Mild lymphocytic infiltrates and rare inflam-

matory cells were seen at this time in the ileum and colon only
(table 1 and figure \F). The difference between the mean lymphoid hyperplasia scores for the 2 genotypes in the duodenum
(P = .002), jejunum (P = .02), ileum (P = .02), and colon
(P = .008) during the patent period was statistically significant.
Mild and moderate villus attenuation with epithelial sloughing was seen at 0 DAO and 7 DAO in the duodenum and at
21 DAO in the colon of BoG2-infected pigs (table 1). All other
intestinal sections showed only mild villus attenuation between
3 DAI and 21 DAO. Comparatively few HuGl-infected pigs
showed mild villus/mucosal attenuation during the patent period, and attenuation was restricted to the ileum and colon
(0-21 DAO; figure 1C and ID). The difference between the
mean villus attenuation scores for the 2 genotypes in the duodenum (P = .007), jejunum (P = .04), and ileum (P = .02)
during the patent period was statistically significant.
Discussion
Infection of day-old gnotobiotic pigs with ^10 HuGl or
BoG2 oocysts resulted in extensive parasite colonization and
disease. It has been suggested that serial passages in a host may
increase virulence, with ingestion of lower doses achieving
higher infection rates and more-severe disease in young gnotobiotic pigs [3]. Our findings suggest otherwise: the minimum
infective dose of each isolate for gnotobiotic pigs was a single
oocyst, after the first pig passage. In addition, the 8-9- and
5-6-day prepatent periods of HuGl and BoG2 isolates in gnotobiotic pigs were evident after the first passage and remained
so after several additional passages. The HuGl isolates also
elicited minimal disease in all subsequent passages, whereas the
BoG2 isolate elicited moderate-to-severe disease accompanied
by loss of weight that often was not regained. Examination of
intestines from pigs in these early and subsequent serial pas-

718

Pereira et al.

sages revealed parasite infection rates, parasite tissue distribution, and pathologic lesions similar to those described in the
present study (L.A.W., unpublished data).
Preliminary studies of 2 other BoG2 and 3 other HuGl isolates in gnotobiotic pigs similarly have shown that all BoG2
strains have shorter prepatent periods (3-6 vs. 8-12 days) and
have elicited more disease than HuGl strains (L.A.W., unpublished data). Thus, the clinical outcome of a C. parvuminfection
in gnotobiotic pigs appears to be determined in part by the
genotype of the parasite, and serial low-dose passage of the C.
parvumused in this study did not significantly alter the strain
virulence for gnotobiotic pigs.
HuGl-infected pigs had significantly more parasites in the
ileum than did the BoG2-infected pigs, yet HuGl-associated
intestinal lesions were only mild to moderate, compared with
BoG2-associated lesions. This apparent discrepancy between
infection intensity and lesion severity may be the result of
unique parasite virulence factors yet to be identified. Differences
in the host's immune response to each genotype may also contribute to the observed discrepancy.
We have demonstrated elsewhere that a strong time-dependent correlation exists between intestinal mucosal cytokine responses, disease onset, intestinal pathology, disease resolution,
and parasite clearance in BoG2-infected pigs [3]. The immune
response to BoG2 parasites may limit parasite load and eliminate infection sooner but simultaneously contribute to pathology and disease, whereas the absence of such a response
would permit greater parasite replication for a longer period
of time, with minimal pathology, as was observed in HuGlinfected pigs in the present study. Comparative studies of the
gnotobiotic pig's cytokine and antibody responses to BoG2 and
HuGl C parvum isolates are under way.
The observed differences between tissue colonization sites for
HuGl and BoG2 C parvum also may help to explain the differences seen in the clinical outcome of infection in the same
host species. BoG2 C. parvum colonized the entire small intestine (duodenum, jejunum, and ileum) and colon, whereas HuGl
C. parvum colonized only the ileum and colon. Because the
upper small intestine is important in regulating absorption of
nutrients and electrolytes, hindrance of its function often leads
to a malabsorptive diarrhea. We noted a loss in epithelial integrity and villus attenuation of the small intestine, which was
associated with the presence of parasites within the epithelial
brush border and moderate-to-severe clinical disease in BoG2infected pigs. Thus, we propose that the colonization site of
the parasite within the host is a determinant of disease expression by that host. A clinical case study in patients with
AIDS who had a history of cryptosporidiosis showed that different anatomic locations of the parasite produced different
disease outcomes [14].

JID 2002; 186 (1 September)

In conclusion, HuGl and BoG2 C. parvum were identified
by RFLP and used to infect gnotobiotic pigs. During sequential
low-dose passages, these isolates showed distinctly differentbiological behaviors in the pig host, in terms of prepatentand patent
periods, disease severity,pathology, and tissue colonization sites,
that correlated with the strain's genotype. Given the increasingly significant molecular and biological differences between
these genotypes that are being identified, reexamination and
redefinition of the Cryptosporidiumtaxa may be in order.
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